The first study of successful pregnancies in Chinese patients with Phenylketonuria
Abstract Background Since the inception of newborn screening programs in China in the 1990s, pregnancy among patients with inherited, metabolic disorders has become more common. This study explores the management and outcomes of planned, full-term pregnancies in patients with phenylketonuria (PKU)....
Main Authors: | Lin Wang, Fang Ye, Hui Zou, Kundi Wang, Zhihua Chen, Qin Hui, Bingjuan Han, Chun He, Xiaowen Li, Ming Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-04-01
|
Series: | BMC Pregnancy and Childbirth |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12884-020-02941-9 |
Similar Items
-
Newborn Screening and Treatment of Phenylketonuria: Projected Health Outcomes and Cost-Effectiveness
by: Huey-Fen Chen, et al.
Published: (2021-05-01) -
Pretreatment cognitive and neural differences between sapropterin dihydrochloride responders and non-responders with phenylketonuria
by: Zoë Hawks, et al.
Published: (2017-09-01) -
Diagnostic and therapeutic recommendations for the treatment of hyperphenylalaninemia in patients 0–4 years of age
by: Ania C. Muntau, et al.
Published: (2018-09-01) -
Long-term efficacy and safety of sapropterin in patients who initiated sapropterin at < 4 years of age with phenylketonuria: results of the 3-year extension of the SPARK open-label, multicentre, randomised phase IIIb trial
by: Ania C. Muntau, et al.
Published: (2021-08-01) -
Italian national consensus statement on management and pharmacological treatment of phenylketonuria
by: Alberto Burlina, et al.
Published: (2021-11-01)